Term ends Nov 12, 2029 · High confidence
20-year base term ends Oct 21, 2029
Held by Biomerieux, Inc.
Filed May 9, 2011 as application 13/125,360 · Granted Jul 15, 2014
Base term plus 22 days of patent term adjustment (USPTO delay)
Today
2009
2029
Clock starts
Oct 21, 2009
Oct 21, 2009
Term ends
Nov 12, 2029
Nov 12, 2029
Granted
Jul 15, 2014
Jul 15, 2014
base term
patent term adjustment
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
22
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 22 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 21, 2009, when application PCT/US2009/061561, the earliest non-provisional in its chain, was filed (this one was filed May 9, 2011) | Oct 21, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +22 days, USPTO patent term adjustment record | Nov 12, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 12, 2029 | High confidence |
Partial family
| Application PCT/US2009/061561 | PCT application no patent term | no patent term |
| US 8,778,615 | this patent Nov 2029 | Nov 2029 |
| US 10,823,733 | Lapsed on the fee record Nov 2024 | Nov 2024 |
| US 11,754,566 | In force Nov 2029 | Nov 2029 |
Partial: 1 of the 4 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 9, 2011 Reel 26249, frame 138 | Gray, Jeff; McPherson, Paul; Nakamura, Kevin; Anderberg, Joseph | Astute Medical, Inc. | Assignment of Assignor's Interest |
| Mar 17, 2014 Reel 32459, frame 246 | Astute Medical, Inc. | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Security Interest |
| Mar 17, 2014 reel/frame not recorded | Astute Medical, Inc. | Capital Royalty Partners II L.P. | Security Interest |
| Mar 17, 2014 reel/frame not recorded | Astute Medical, Inc. | Capital Royalty Partners II - Parallel Fund "a" L.P. | Security Interest |
| Mar 17, 2014 reel/frame not recorded | Astute Medical, Inc. | Parallel Investment Opportunities Partners II L.P. | Security Interest |
| Nov 12, 2015 Reel 37207, frame 287 | Astute Medical, Inc. | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Corrective Assignment to Correct the Application Number 61831594 Previously Recorded at Reel: 032459 Frame: 0246. Assignor(S) Hereby Confirms the Security Agreement. |
| Nov 12, 2015 reel/frame not recorded | Astute Medical, Inc. | Capital Royalty Partners II L.P. | Corrective Assignment to Correct the Application Number 61831594 Previously Recorded at Reel: 032459 Frame: 0246. Assignor(S) Hereby Confirms the Security Agreement. |
| Nov 12, 2015 reel/frame not recorded | Astute Medical, Inc. | Capital Royalty Partners II - Parallel Fund "a" L.P. | Corrective Assignment to Correct the Application Number 61831594 Previously Recorded at Reel: 032459 Frame: 0246. Assignor(S) Hereby Confirms the Security Agreement. |
| Nov 12, 2015 reel/frame not recorded | Astute Medical, Inc. | Parallel Investment Opportunities Partners II L.P. | Corrective Assignment to Correct the Application Number 61831594 Previously Recorded at Reel: 032459 Frame: 0246. Assignor(S) Hereby Confirms the Security Agreement. |
| May 4, 2018 Reel 46077, frame 84 | Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P. | Astute Medical, Inc. | Release of Security Interest |
| Jan 8, 2025 Reel 69778, frame 363 | Astute Medical, Inc. | Biomerieux, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2029
Term ends Nov 12, 2029. No further fees fall due before then
Note
The 22 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
40
later US patents cite this one
That is top 25% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.